by In2Pharma | Jun 6, 2023 | News
Europe Following a question from a member state, the European Court has ruled that certain forms of price indications can incite irrational use, which is not allowed in public advertising of OTC medicines. They decided that the following situations incite irrational...
by In2Pharma | Mar 7, 2017 | News
As a result of prolonged use and overuse of nasal decongestants, the Belgian Health Authorities have decided to switch intranasal corticosteroids to OTC-status. OTC-use is recommended especially for intranasal corticosteroids with low systemic absorption e.g....
